Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Dr Caroline Hendricks
-
caroline.stevenson@manchester.ac.uk


Dr Daniel Pratt
+44 (0)161 306 0400
Daniel.pratt@manchester.ac.uk


More information about this study, what is involved and how to take part can be found on the study website.

Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Prevention of suicide behaviour in prison (work packages 3 and 4)
Back

Prevention of suicide behaviour in prison (work packages 3 and 4)

Recruiting

Open to: All Genders

Age: Adult

$location.addressLine3

Medical Conditions

Suicidal behaviour

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


The rate of suicide in prisons in the UK has doubled in the last ten years and represents a significant problem. Cognitive Behavioural Suicide Prevention (CBSP) is a psychological intervention that aims to address suicidal behaviour. In a small trial of CBSP, the therapy group was found to have engaged in fewer suicidal behaviours compared to controls. However, the study could not provide any definitive comment on efficacy. The pilot trial found that many participants in the treatment arm required substantial ‘pre-intervention support’ in order for the necessary open, warm therapeutic relationship to develop. The need for further modification to the standard delivery of CBSP therapy was identified. These modifications, including ‘pre-intervention support’ were addressed in the first two work packages of the research programme (submitted under IRAS ID: 266858) to produce the Prospect Programme.
This application represents the next phase of the research programme and involves assessing the clinical and cost-effectiveness of the new PROSPECT programme in a Randomised Controlled Trial (RCT). This application covers work packages 3 and 4.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

17 Mar 2022 31 Dec 2025

Publications

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/39695433/ (added 19/12/2024)

Work package 3:
We will conduct an RCT in four UK prisons, recruiting 360 participants who are currently detained in prison and are feeling suicidal. We will assess participants at baseline and then again six months later. After baseline assessments, half will be randomised to receive the PROSPECT programme plus treatment as usual and the other half will receive treatment as usual. We will then compare the two groups to determine whether the intervention was clinically and cost-effective. The study will take 27 months to complete.

Work package 4:
Alongside the RCT, we will conduct a process evaluation to assess the extent to which the intervention was delivered to participants in the PROSPECT programme group and to enhance our understanding of how the intervention worked.


Male adults (aged over 18 years) who are currently detained in prison and are feeling suicidal

You can take part if:


Current inclusion criteria as of 14/03/2022:

For the RCT (WP3):
1. Male Prisoner (defined as a person sentenced to imprisonment in a male prison)
2. Aged over 18 years - updated 07/03/2022: aged 18 years or over
3. At current risk of suicide behaviour as indicated by currently being on the host prison's ACCT system, or on the ACCT system within the four weeks prior to consent.
4. Able to complete a battery of self-report measures with breaks if needed
5. Willing to consent to being subject to a 'holding order' to require them to remain within the host prison for the duration of their participation in the trial.

For the Process Evaluation Interviews (WP4)
Prison participants:
1. Is a participant on the Prospect RCT randomised to receive the Prospect programme.
Staff participants:
2. Is a member of staff currently working in the prison in a role that involves the care and/or management of prisoners who engage in suicide behaviour.
OR
3. Is a member of staff directly involved in delivering the Prospect programme.

Observation study:
Shadowing of prisoner participants:
1. Is a participant on the Prospect RCT randomised to receive the Prospect programme.
Staff participants:
2. Is a member of staff currently working in the prison in a role that involve the care and/or management of prisoners who engage in suicide behaviour.
3. Has taken part in the process evaluation interviews
But observation could also include:
Any prisoner or member of staff present dur


You may not be able to take part if:


For the RCT (WP3):1. Planned release within next 9 months2. Insufficient knowledge of English to enable adequate participation in the assessment process3. Deemed by prison staff to be too dangerous/elevated risk of harm to the researcher4. Lacking capacity to provide informed consent

For the process evaluation (WP4):Prison participants:1. Deemed by prison staff to be too dangerous/elevated risk of harm to the researcher

Staff participants:There are no exclusion criteria for staff participants

Observation study:1. Any member of staff or prisoner who informs the researcher that they do not wish to be included in the observation study.


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • 4 prisons in the North of England
    M13 9PL

There is no direct benefit for people in prison and staff participants who take part in the study. However, some participants may find it helpful to talk about their experiences and may be satisfied that they are contributing to an important area that aims to improve suicide prevention in prison. There is a risk that some people may find it distressing when answering questions about suicide, but previous studies have found that individuals are more likely to derive benefit from discussing suicide than experience harm.

Dr Caroline Hendricks
-
caroline.stevenson@manchester.ac.uk


Dr Daniel Pratt
+44 (0)161 306 0400
Daniel.pratt@manchester.ac.uk



More information about this study, what is involved and how to take part can be found on the study website.


The study is sponsored by University of Manchester and funded by NIHR Central Commissioning Facility (CCF); National Institute for Health Research (NIHR) (UK).



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: ISRCTN14056534

Or CPMS 50267

Last updated 19 December 2024

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top